Balligand, Marc ; Université de Liège - ULiège > Département clinique des animaux de compagnie et des équidés > Chirurgie et clinique chirurgicale des petits animaux
ABATANGELO G., BOTTI P., DELBUE M., Intra-articular sodium hyaluronate injections in the Pond-Nuki experimental model of osteoarthritis in dogs. I. Biochemical results. Clin. Orthop. 1989, 241 : 278-285.
ABRAMSON S.B., WEISSMAN G. The mechanisms of action of nonsteroidal antiinflammatory drugs. Arthritis. Rheum. 1989, 32 : 1.
ASARI A., MIYAUCHI S., MATSUZAKA S. et al. Molecular weight-dependent effects of hyaluronate on the arthritic synovium. Arch. Histol. Cytol. 1998, 61(2) : 125-135.
AUCOIN D. P. Drug therapy in the geriatric animal : the effect of aging on drug disposition. Vet. Clin. North. Am. Small Anim. Pract. 1989, 19: 41.
BADURSKI J., JEZIERNICKA E., NARUSZEWICZ K. et al. Comparative analysis of three treatment regimens for treating gonarthritis with calcitonin, naproxen and flavonoids based on EULAR criteria and visual analogue scale. Pol. Tyg. Lek. 1995, 50(44-47) : 37-40.
BALLIGAND M., JAKOVLJEVIC S. Utilisation d'un copolymère d'acides gras (ARA 3000 Beta) dans le traitement de l'arthrose chez le chien. Ann. Méd. Vét. 1987, 131 : 89-96.
BASSLEER C., MAGOTTEAUX J., GEENEN V. et al Effects of meloxicam compared to acetylsalicylic acid in human articular chondrocytes. Pharmacology. 1997, 54(1) : 49-56.
BATES R.E., GREMILLION H.A., STEWART C.M. Degenerative joint disease. Part I : Diagnosis and management considerations. Cranio. 1993, 11(4) : 284-290.
BEALE B.S. Arthropathies. In BLOOMBERG M.S., DEE J.F., TAYLOR R.A. (Eds) : Canine Sports Medicine and Surgery. W.B. Saunders Company 1998 : 210-222.
BEHRENS F., SHEPARD N., MITCHELL N. Alterations of rabbit articular cartilage by intra-articular injections of glucocorticoids. J. Bone Joint Surg. Am. 1975, 57 : 70-76.
BENNETT D. Joints and joint diseases. In WHITTlCK W.G. (Ed). Canine orthopaedics. 2nd Ed. Philadelphia, Lea & Febiger. 1990: 761-857.
BENNETT D., MAY C.M. Joint diseases of dogs and cats. In ETTINGER S.J., FELDMAN E.C. (Eds). Textbook of Veterinary Internal Medicine. W.B. Saunders, Philadelphia. 1995 : 2032-2077.
BENNETT W.M., HENRICH W.L., STOFF J.S. The renal effects of nonsteroidal anti-inflammatory drugs: summary and recommendations. Am. J. Kidney Dis. 1996, 28 : 56-62.
BENTON H.P., VASSEUR P.B., BRODERICK-VILLA G.A. Effect of carprofen on sulfated glycosaminoglycan metabolism, protein synthesis, and prostaglandin metabolism by cultured canine osteoarthritic chondrocytes. Am. J. Vet. Res. 1997, 58 : 286.
BIRKDEL-HANSEN H., MOORE W.G., BODDEN M.K. Matrix metalloproteinase : A review. Crit. Rev. Oral. Biol. Med. 1993, 4 : 197-250.
BLACKBURN W.D. Management of osteoarthritis and rheumatoid arthritis : prospects and possibilities. Am. J. Med. 1996, 100(2A) : 24S-30S.
BOOTHE D., CAMP R., GELSAND L. Roundtable discussion of degenerative joint disease in dogs. Canine Pract. 1996, 21 : 1.
BOOTHE D.M. Controversy : NSAID vs chondroprotective disease modifying agents for the treatment of osteoarthritis. 65th Annual Meeting American Animal Hospital Association : Chicago, 1998.
BOUCK G.R., MILLER C.W., TAVES C.L. A comparison of surgical and medical treatment of fragmented coronoid process and osteochondritis dissecans of the canine elbow. Vet. Comp. Orthop. Trauma. 1995, 8 : 177.
BRANDT K.D. Effects of nonsteroidal anti-inflammatory drugs on chondrocyte metabolism in vivo. Am. J. Med. 1987. 83 (Suppl. 5A) : 29-34.
BROMILEY M.W. Physiotherapy in athletic dogs. In Physiotherapy in Veterinary Medicine. Oxford, England, Blackwell Scientific. 1991 : 10-36.
CALDWELL J.R. Intra-articular corticosteroids. Guide to selection and indication for use. Drugs. 1996, 52(4) : 507-514.
CAMPBELL K.L. Therapeutic indications for dietary lipids. In KIRK R.W., BONAGURA J.D. (Eds). Current Veterinary Therapy XI. Small Animal Practice. Philadelphia, W.B. Saunders. 1992 : 36-39.
CHERAS P.A., SMITH K.R. Clinical effects and associated changes in coagulation profile in pentosan polysulfate treated osteoarthritic dogs. Proceedings 25th Annual Conference of the Veterinary Orthopedic Society. Snowmass. Colorado, February 1998.
COLLIER M.A., CLARK D., DEBAULT L. et al. The distribution of radiolabeled PSGAG in canine synovial fluid and articular cartilage after intramuscular injection of 3HPSGAG. Canine Practice. 1998, 23(5) :6-9.
COMER J.S., KINCAID S.A., BAIRD A.N. Immunolocalization of stromelysin tumor necrosis factor (TNF) alpha and TNF receptors in atrophied canine articular cartilage treated with hyaluronic acid and transforming growth factor beta. Am. J. Vet. Res. 1996, 57: 1486.
COUGHLAN A.R. Osteoarthritis. In GORMAN N.T. (Ed). Canine Medicine and Therapeutics. 4th Ed. Blackwell Science Ltd, UK. 1998 : 770-780.
DEAN D.D., MARTEL-PELLETIER J., PELLETIER J.P. et al. Evidence for metalloproteinase and metalloproteinase inhibitor imbalance in human osteoarthritic cartilage. J. Clin. Invest. 1989, 84: 678-685.
DECAMP C.E., FLO G.L., MARTINEZ S.A. et al. Double blind study to evaluate the clinical response to gold bead acupuncture as a treatment in dogs with naturally occurring hip dysplasia. Proceedings 25th Annual Conference of the Veterinary Orthopedic Society. Snowmass, Colorado. February 1998.
DEHAAN J.J., GORING R., BEALE B.S. Evaluation of polysulfated polyglycosaminoglycan for the treatment of hip dysplasia in dogs. Vet. Surg. 1994, 23 : 177-181.
DINGLE J.T. Cartilage maintenance in osteoarthritis : interaction of cytokines, NSAID and prostaglandins in articular cartilage damage and repair. J. Rheumatol. Suppl 1991, 28 : 30-37.
DOWNER A.H. Therapeutic exercise. In Physical Therapy for Animals : Selected Techniques. Springfiels, IL, Charles C. Thomas. 1978 : 153-158.
DRAY A., URBAN L. New pharmacological strategies for pain relief. Annu. Rev. Pharmacol. Toxicol. 1996, 36 : 253-280.
ERIKSSON S.V., LUNDEBERG T. LUNDEBERG S. Interaction of diazepam and naloxone on acupuncture induced pain relief. Am. J. Chin. Med. 1991, 19(1) : 1-7.
FARQUHAR T., TODHUNTER R.J., FUBINI S.L. Effect of methylprednisolone and mechanical loading on canine articular cartilage in expiant culture. Osteoarthr. Cartil. 1996, 4 : 55.
FELSON D.T. Weight and osteoarthritis. J. Rheumatol. 1995 Suppl. 43, 7-9.
FISCHER H.P., EICH W, RUSSEL I.J. A possible role for saliva as a diagnostic fluid in patients with chronic pain. Semin. Arthritis. Rheum. 1998, 27(6) : 348-359.
FITZPATRICK P.L., MORGAN D.A. Fresh osteochondral allografts : a 6-10 year review. Aust. N. Z. J. Surg. 1998, 68(8) : 573-579.
FOX S.M., JOHNSTON S.A. Use of car ∧ profen for the treatment of pain and inflammation in dogs. J. Am. Vet. Med. Assoc. 1997, 210(10) : 1493-1498.
FRISBIES D.D., NIXON A.J. Insulin-like growth factor 1 and corticosteroid modulation of chondrocyte metabolic and mitogenic activities in interleukin 1-conditioned equine cartilage. Am. J. Vet. Res. 1997, 58(5) : 524-530.
FROLICH J.C. Prostaglandin endoperoxide synthetase iso enzymes : the clinical relevance of selective inhibition. Ann. Rheum. Dis. 1995, 54 : 942-943.
FURST D.E., PAULUS H.E. Aspirin and other nonsteroidal antiinflammatory drugs. In MCCARTY D.J., KOOPMAN W.J. (Eds). Arthritis and allied conditions, 12th ed. Philadelphia, Lea & Febiger. 1993 : 567-602.
GABRIEL S.E., JAAKKIMAINEM L., BOMBARDIER C. Risk for serious gastrointestinal complications related to use of nonsteroidal anti-inflammatory drugs : a meta-analysis. Ann. Intern. Med. 1991, 115 : 787-796.
GEUSENS P., WOUTERS C., NIJS J. Long-term effects of omega-3 fatty acid supplementation in active rheumatoid arthritis : A 12-month double blind, controlled study. Arthritis Rheum. 1994, 37 : 824-829.
GHOSH P., SMITH M., WELLS C. Second-line agents in osteoarthritis. In DIXON J.S., FURST D.E. (Eds). Second-Line Agents in the Treatment of Rheumatic Diseases. New York, Marcel Dekker, Inc. 1993 : 1105-1110.
GOLDBERG V.M., CAPLAN A.L. Biological resurfacing: an alternative to total joint arthroplasty. Orthopedics. 1994, 17(9) : 819-821.
GROUSSON D., MOISSONNIER P., TUSSEAU C. Utilisation d'un polymère d'acides gras saturés el insaturés sodés (ARA 3000 Beta) dans le traitement de la dysplasie de la hanche chez le chien. Prat. Med. Chir. Anim. Comp. 1990. 25(2) : 159-167.
HARDIE E.M. Management of acute pain. Proceedings 15th ACVIM Forum. Lake Buena Vista, FL. 1997 : 77-79.
HELLIO M.P., PESCHARD M.J., COHEN C. et al. Calcitonin inhibits phospholipase A2 and collagenase acticity of human osteoarthritic chondrocytes. Osteoarthritis. Cartilage 1997, 5(2) : 121-128.
HODGES C.C., PALMER R.H. Post operative physical therapy. In HARARI J (Ed). Surgical Complications and Wound Healing in Small Animal Practice. Philadelphia, W.B. Saunders. 1993 : 389-405.
HOWARD R.D., MCILWRAITH C.W. Hyaluronan and its use in the treatment of equine joint disease. In MCILWRAITH C.W., TROTTER G.W. (Eds). Joint Disease in the Horse. Philadelphia, WB Saunders. 1996, 257.
HULSE D. Treatment methods for pain in the osteoarthritic patient. Vet. Clin. North. Am. Small. Anim. Pract. 1998, 28(2) : 361-375.
HULSE D.S., HART D., SLATTER M. et al. The effect of Cosequin in cranial cruciate deficient and reconstructed stifle joints in dogs. Proceedings 25th Annual Conference of the Veterinary Orthopedic Society. Snowmass, Colorado, February 1998.
HURTIG M., EVANS P., CLARNETTE R. et al. Mosaicplasty for resurfacing the equine third carpal bone. Proceedings 25th Annual Conference of the Veterinary Orthopedic Society. Snowmass, Colorado. February 1998.
JANSSENS L.A. Observations on acupuncture therapy of chronic osteoarthritis in dogs : a review of 61 cases. J. Sm. Anim. Pract. 1986, 27(12) : 825-837.
JOHNSON K.A., DAVIES P.E. Drug therapy in surgical musculoskeletal disease. In BOJRAB M.J. (Ed). Disease Mechanisms in Small Animal Surgery. 2nd Ed. Lea & Febiger, Philadelphia. 1993 : 1105-1111.
JOHNSTON SA. Osteoarthritis : joint anatomy, physiology, and pathobiology. Vet. Clin. North. Am. Small. Anim. Pract. 1997, 27(4): 699-723.
JOHNSTON SA, FOX SM. Mechanisms of action of anti-inflammatory medications used for the treatment of osteoarthritis. J. Am. Vet. Med. Assoc. 1997, 210(10) : 1486-1492.
JOHNSTON S.A., BUDSBERC S.C. Nonsteroidal anti-inflammatory drugs and corticosteroids for the management of canine osteoarthritis. Vet. Clin. North. Am. Small. Anim. Pract. 1997, 27(4): 841-862.
KAMERLING S.G. New Targets for Analgesic Drug Development. Proceedings of the 15th ACVIM Forum, Lake Buena Vista, FL, 1997.
KEALY R.D., LAWLER D.F, BALLAM J.M. Five-year longitudinal study on limited food consumption and development of osteoarthritis in coxofemoral joints of dogs. J. Am. Vet. Med. Assoc. 1997, 210 : 222-225.
KOPP E., GHOSH S. Inhibition of NF-kappa B by sodium salicylate and aspirin. Science. 1994, 265 : 2017-2019.
KOTHBAUER O. Implantation of gold particles at acupuncture points for controlling painful disorders of the hip joints in three dogs. Wiener. Tierarztliche. Monatsschrift. 1997, 84(2) : 47-52.
KRAUS V.B. Pathogenesis and treatment of osteoarthritis. Med. Clin. North. Am. 1997, 81(1) : 85-112.
KREMER J.M., LAWRENCE D.A., JUBISZ W. Dietary fish oil and olive oil supplementation in patients with rheumatoid arthritis. Clinical and immunological effects. Arthritis Rheum. 1990, 33 : 810-820.
KREMER J.M., LAWRENCE D.A., PETRILLO G.F. Effects of high-dose fish oil on rheumatoid arthritis after stopping nonsteroidal anti-inflammatory drugs. Clinical and immune correlates. Arthritis Rheum. 1995, 38 : 1107-1114.
KUBOTA E., IMAMURA H., KUBOTA T. et al. Interleukin 1 beta and stromelysin (MMP3) activity of synovial fluid as possible markers of osteoarthritis in the temporomandibular joint. J. Oral. Maxillofac. Surg. 1997, 55(1) : 20-28.
LANEUVILLE O., BREUER D.K., DEWITT D.L. Differential inhibition of human prostaglandin endoperoxide H synthases-1 and -2 by nonsteroidal anti-inflammatory drugs. J. Pharmacol. Exp. Ther. 1994, 271 : 927-934.
LAU C.S., MORLEY K.D., BELCH J.J.F. Effects of fish oil supplementation on non-steroidal anti-inflammatory drug requirement in patients with mild rheumatoid arthritis. A double blind placebo controlled study. Br. J. Rheamatol. 1993, 32: 982-989.
LEES P. Inflammation and the pharmacology of anti-inflammatory drugs. Proceedings 15th ACVIM Forum. Lake Buena Vista, FL. 1997 : 60-64.
LEVINE D., MILLIS D.L. Veterinary medicine and the PT : Not just pet therapy. PT Mag. Phys. Therapy. 1996, 4 : 38.
LEWIS R.H. Development of elbow arthroplasty (canine) clinical trials. In Proceedings 6th Annual ACVS Veterinary Symposium, San Francisco. 1996 : 110.
LITTLE C., GHOSH P. Potential use of pentosan polysulfate for the treatment of equine joint disease. In MCILWRAITH C.W., TROTTER G.W. (Eds). Joint Disease in the Horse. Philadelphia. WB Saunders, 1996 : 281.
LOTZ M., BLANCO F.J., VON KEMPIS J. et al. Cytokine regulation of chondrocyte functions. J. Rheumatol. Suppl. 1995,43 : 104-108.
LUST G., WILLIAMS A.J., BURTON-WURSTER N. Effects of intramuscular injections of glycosaminoglycan polysulfates on signs of incipient hipdysplasia in growing dogs. Am. J. Vet. Res. 1992,53: 1836-1843.
MACPHAIL C.M. Medical management for canine osteoarthritis. Proceedings 16th ACVIM Forum. San Diego, CA. 1998 : 463-465.
MAY S.A., LEES P. Nonsteroidal anti-inflammatory drugs. In McIIAVRAITH C.W., TROTTER G.W. (Eds). Joint Disease in the Horse. Philadelphia. W.B. Saunders. 1996 : 223-237.
MAYNOU C., MESTDAGH H., BELTRAND E. et al Résultats à long terme de l'autogreffe ostéo-cartilagineuse de voisinage dans les destructions cartilagineuses étendues du genou. A propos de 5 cas. Acta. Onthop. Belg. 1998, 64(2) : 193-200.
MCCAFFERTY D.M., GRANGER D.N., WALLACE J.L. Indomethacin-induced gastric injury and leukocyte adherence in arthritic versus healthy rats. Gastroenter. 1995, 109 : 1173.
MCNAMARA P.S., BARR S., ERB H. Hematologic, hemostatic and biochemical effects in dogs receiving an oral chondroprotective agent for thirty days. Am. J. Vet. Res. 1996, 57: 1390.
MCNAMARA P.S., BARR S.C., LIPPIELLO L. Effects of an oral chondroprotective agent (Cosequin) on cartilage metabolism and canine serum. In Proceedings of the 24th Vet. Orthop. Society Meeting. Big Sky, M.T., 1997.
MCKEAG D.B. The relationship of osteoarthritis and exercise. Clin. Sports. Med. 1992, 11 : 471.
MILLER W.H., SCOTT D.W., WELLINGTON J.R. Treatment of dogs with hip arthritis with a fatty acid supplement. Canine Pract. 1992, 17 : 6-8.
MILLIS D.L., LEVINE D. The role of exercise and physical modalities in the treatment of osteoarthritis. Vet. Clin. North. Am. Small. Anim. Pract. 1997, 27(4) : 913-930.
MILLIS D.L., KORVICK D., DEAN D. et al. Effect of polysulfated glycosaminoglycan on articular cartilage in a Pond-Nuki model of osteoarthritis. Proceedings 25th Annual Conference of the Veterinary Orthopedic Society. Snowmass, Colorado, February 1998.
MUNROE D.G., LAU C.Y. Turning down the heat: new routes to inhibition of inflammatory signaling by prostaglandin H, synthases. Chem. Biol. Interact. 1995, 2 : 343-350.
MURRAY R.C., DEBOWES R.M., GAUGHAN E.M. et al. The effects of intra-articular methylprednisolone and exercise on the-mechanical properties of articular cartialge in the hirse. Osteoarthritis. Cartilage 1998, 6(2) : 106-1 14.
NIXON A.J., FORTIER L.A., WILLIAMS J. etal. Repair of large full-thickness articular defects in horses with insulin-like growth factor-I laden fibrin composites. Proceedings 25th Annual Conference of the Veterinary Orthopedic Society. Snowmass, Colorado. February 1998.
ODDIS C.V. New perspectives on osteoarthritis. Am. J. Med. 1996 Feb 26, 100(2A) : 10S-15S.
PALMOSKI M.J., BRANDT K.D. In vivo effect of aspirin on canine osteoarthritic cartilage. Arthritis. Rheum. 1983, 26 : 994.
PALMOSKI M.J., BRANDT K.D. Effects of altered load on canine articular cartilage in vivo and in vitro. Int. J. Sports. Med. 1984, 5 : 79.
PAPICH M.G. Management of chronic pain. Proceedings 15th ACVIM Forum. Lake Buena Vista, FL. 1997 : 74-76.
PELLETIER J.P., MARTEL-PELLETIER. The pathogenesis of osteoarthritis and the implication of the use of hyaluronan and hylan as therapeutic agents in viscosupplementation. J. Rheumatul. 1993, 20 Suppl 39 : 19-24.
PELLETIER J.P., CLOUTIER J.M., MARTEL-PELLETIER J. In vitro effects of NSAIDS and corticosteroids on the synthesis and secretion of interleukin 1 by human osteoarthritic synovial membranes. Agents. Actions. Suppl. 1993, 39 : 181-193.
PELLETIER J.P, MARTEL-PELLETIER J. Effects of nimesulide and naproxen on the degradation and metalloprotease synthesis of human osteoarthritic cartialge. Drugs. 1993, 46 Suppl I : 34-59.
PELLETIER J.P., DIBATTISTA J.A., RAYNAULD J.P. et al. The in vivo effects of intraarticular corticosteroid injections on cartilage lesions, stromelysin, interleukin-1. and oncogene protein synthesis in experimental osteoarthritis. Lab. Invest. 1995, 72(5) : 578-586.
PELLETIER J.R, MINEAU F., FERNANDES J. et al. Two NSAIDs, nimesulide and naproxen, can reduce the synthesis of urokinase and 1L-6 while increasing PAI-1, in human OA synovial fibroblasts. Clin. Exp. Rheumatol. 1997, 15(4) : 593-398.
PERROT S., MENKES C.J. Nonpharmacological approaches to pain in osteoarthritis. Available options. Drugs. 1996, 52 Suppl 3 : 21-26.
PETERSSON I.F., SANDQVIST L., SVENSSON B., SAXNE T. Cartilage markers in synovial fluid in symptomatic knee osteoarthritis. Ann. Rheum. Dis. 1997, 56(1) : 64-67.
PIERMATTEI D.L., FLO G.L. Arthrology. In PIERMATTEI D.L., FLO G.L. (Eds). Handbook of small animal orthopedics and fracture repair. 3rd Ed. W.B. Saunders. 1997 :170-200.
RATCLIFFE A., ROSENWASSER M.P., MAHMUD F. et al. The in vivo effects of naproxen on canine experimental osteoarthritic articular cartilage : composition, metalloproteinase activities and metabolism. Agents Actions Suppl. 1993, 39 : 207-211.
READ R.A., CULLIS-HILL D. The systemic use of the chondroprotective agent pentosan polysulfate in the treatment of osteoarthritis. Results of a double-blind clinical trial in dogs. Proceedings Annual Meeting Vet. Orthop. Society. Lake Louise, Canada. 1993 : 32.
READ R.A., CULLIS-HILL D., JONES M.P. Systemic use of pentosan polysulfate in treatment of osteoarthritis. J. Small Anim. Pract. 1996, 37 : 108.
RYAN M.E., GREENWALD R.A., GOLUB L.M. Potential of tetracyclines to modify cartilage breakdown in osteoarthritis. Curr. Opin. Rheumatol. 1996, 8 : 238.
SACKMAN. Pain and its management. Vet. Clin. North. Am. Small. Anim. Pract. 1997, 27(6) : 1487-1504.
SALVEMINI D. Cytoprotective effects of iNOS inhibitors in disease models. Proceedings 2nd Annual Anti-inflammatory Drug Discovery Summit. Strategic Research Institute, Princeton, N.J., 1996.
SCHIAVINATO A., LINI E., GUIDOLIN D. Intraarticular sodium hyaluronate injections in the Pond-Nuki experimental model of osteoarthritis in dogs. 11. Morphological findings. Clin. Orthop. 1989,241 : 286-299.
SCHOEN A.M. Acupuncture for musculoskeletal disorders. Probl. in Vet. Med. 1992, 4(1) : 88-97.
SCHRADER S.C. Joint diseases of the dog and cat. In OLMSTEAD M.L. (Ed). Small Animal Orthopedics. St Louis, Mosby. 1995 : 437-471.
SCHRAGER M. Slimming down reduces arthritis risk. Phys. Sports. Med. 1995, 23 : 22.
SEE Y., NG S.C., THO K.S. et al. Are antacids necessary as routine prescriptives with non-steroidal anti-inflammatory drugs? Ann. Acad. Med. Singapore. 1998, 27(2) : 219-222.
SHOEMAKER R.S., BERTONE A.L., MARTIN G.S. Effects of intra-articular administration of methylprednisolone acetate on normal articular cartilage and on healing of experimentally induced osteochondral defects in horses. Am. J. Vet. Res. 1992, 53: 1446-1453.
SIMON L.S. Actions and toxicity of nonsteroidal anti-inflammatory drugs. Curr. Opin. Rheumatol. 1996, 8(3) : 169-175.
SMITH R.L., KAJIYAMA G., LANE N.E. Nonsteroidal anti-inflammatory drugs : effects on normal and interleukin 1 treated human articular chondrocyte metabolism in vitro. J. Rheumatol. 1995, 22(6) : 1130-1137.
SRINIVAS G.R., CHICHESTER C.O., BARRACH H.J. el al Effects of certain antiarthritic agents on the synthesis of type II collagen and glycosaminoglycans in rat chondrosarcoma cultures. Agents. Actions. 1994, 41(3-4) : 193-199.
STAUFFER K., MCCARTHY P., WILLEFORD K. et al. Polysulfated glycosaminoglycan treatment of canine adjuvant synovitis - Clinical, synovial fluid protein and protease responses. Proceedings 25th Annual Conference of the Veterinary Orthopedic Society. Snowmass, Colorado, February 1998.
TANAKA S., HAMANISCHI C., KIKUCHI H. et al. Factors related to degradation of articular cartialge in osteoarthritis : a review. Semin. Arthritis. Rheum. 1998, 27(6) : 392-399.
TAYLOR R.A. Postsurgical Physical Therapy : The Missing Link. Compend. Contin. Educ. Pract. Vet. 1992, 14(12) : 1583-1593.
TESTA V., CAPASSO G., MAFFULLI M. et al. Proteases and antiproteases in cartilage homeostasis. Abrief review. Clin. Orthop. 1994, 306 : 79-84.
TOCCI M.J. Interleukin-1B converting enzyme. Proceedings of the 2nd Annual Anti-inflammatory Drug Discovery Summit, Strategic Research Institute, Princeton, NJ., 1996.
TODHUNTER R.J., LUST G. Polysulfated glycosaminoglycan in the treatment of osteoarthritis. J. Am. Vet. Med. Assoc. 1994, 205(8) : 1245-1251.
TODHUNTER R.J., FUBINI S.L., WOOTON J.A. Effects of methylprednisolone acetate on proteoglycan and collagen metabolism of articular cartilage explants. J. Rheumatol. 1996, 23 : 1207.
TODHUNTER R.J., FUBINI S.L., VERNIER-SINGER M. et al. Acute synovitis and intra-articilar methylprednisolone acetate in ponies. Osteoarthritis. Cartilage. 1998, 6(2) : 94-105.
TURNER T.M. Canine total stifle arthroplasty. In Proceedings 5th Annual American College of Veterinary Surgeons Veterinary Symposium. Chicago. 1995 : 74.
URQUHART E. Central analgesic activity of nonsteroidal antiinflammatory drugs in animal and human pain models. Semin. Arthritis. Rheum. 1993, 23 : 198-205.
VANE J.R., BOTTING R.M. A better understanding of antiinflammatory drugs based on isoforms of cyclooxygenase (COX-1 and COX-2). Adv. Prostagl. Thrombox. Leukot. Res. 1995, 23 : 41-48.
VIGNON E. Non-steroidal anti-inflammatory drugs (NSAIDs) and cartilage. Rheumatology in Europe. 1994, 23 : 27-28.
WALLACE J. Mechanisms of non-steroidal anti-inflammatory drug (NSAID) induced gastrointestinal damage-potential for development of gastrointestinal tract safe NSAIDs. Can. J. Physiol. Pharmacol. 1994, 72 : 1493.
WILDER R.L. Corticosteroids. In KOOPMAN W.J. (Ed). Arthritis ans Allied Conditions. 13th Ed. Baltimore, Williams & Wilkins. 1997: 731.
WOESSNER J.F., Matrix metalloproteinases and their inhibitors in connective tissue remodeling. FASEB Journal 1991, 5 : 2145-2154.
WRIGHT V. Historical overview of non-steroidal anti-inflammatory drugs. Br. J. Rheumatol. 1995, 34 Suppl 1 : 2-4.
YU L.P., SMITH G.N., BRANDT K.D. Reduction of the severity of canine osteoarthritis by prophylactic treatment with oral doxycycline. Arthritis Rheum. 1992, 35 : 1150.
YU L.P., BURR D.B., BRANDT K.D. Effects of oral doxycycline administration on histomorphometry and dynamics of subchondral bone in a canine model of osteoarthritis. J. Rheumatol. 1996 , 23: 137.